What is phase 2 testing?

Phase 2 testing is a crucial stage in clinical trials that evaluates the efficacy and side effects of a drug or treatment in a larger group of participants, typically ranging from 100 to 300 individuals. This phase aims to determine whether the treatment is effective for a specific condition and to further assess its safety profile. It follows successful Phase 1 trials, which primarily focus on safety and dosage. Phase 2 results help inform the decision to advance to Phase 3 trials, where the treatment is tested in a larger population.